Back to Search Start Over

TREATMENT OF BILATERAL DIFFUSE UVEAL MELANOCYTIC PROLIFERATION WITH INTRAVITREAL STEROID IMPLANTS.

Authors :
Gemperline, Taylor P.
Smith, Bradley T.
Source :
Retinal Cases & Brief Reports; Jul2022, Vol. 16 Issue 4, p461-465, 5p
Publication Year :
2022

Abstract

A patient with bilateral diffuse uveal melanocytic proliferation is treated with intravitreal steroid implants, resulting in improvement of visual acuity, macular edema, and choroidal thickening. Background/Purpose: To report a case of bilateral diffuse uveal melanocytic proliferation (BDUMP) treated with intravitreal steroid implants. Method: Bilateral diffuse uveal melanocytic proliferation was diagnosed and treated with intravitreal steroid implants (both dexamethasone 0.7 mg [intravitreal dexamethasone implants] and fluocinolone acetonide 0.18 mg [intravitreal fluocinolone acetonide implants]) and monitored every 2 weeks to 4 weeks with optical coherence tomography. Results: Intravitreal dexamethasone implants improved visual acuity and central retinal thickness for 10 weeks, was best from 4 to 6 weeks, and recurred by 14 weeks after treatment. Intravitreal fluocinolone acetonide implants improved visual acuity and central retinal thickness for 20 weeks after treatment without edema recurrence. No retinal detachments were observed over 1 year of treatment. Conclusion: Intravitreal steroid implants resulted in visual acuity improvement and central retinal thickness reduction for up to 20 weeks and may protect against retinal detachments in patients with bilateral diffuse uveal melanocytic proliferation. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
19351089
Volume :
16
Issue :
4
Database :
Supplemental Index
Journal :
Retinal Cases & Brief Reports
Publication Type :
Academic Journal
Accession number :
157663598
Full Text :
https://doi.org/10.1097/ICB.0000000000001008